Edwards Lifesciences Corporation (EW) is listed on NYSE in the Healthcare sector Β· Medical Devices industry. The current price is 90.87, up 0.41% from the previous close. Market cap is approximately $52.3B.
The commentary below is auto-generated by comparing market data (P/E, ROE, D/E, etc.) against predefined thresholds. No LLM is used. This is not a buy/sell recommendation from us or any analyst. For reference only.
EW's 53.77x P/E is in premium territory. Justifiable while growth accelerates, but this is also the band that reacts first to guidance cuts or macro shocks.
An ROE of 9.18% is standard territory. Without a clear differentiator, expect the figure to drift toward the industry mean over time.
Edwards Lifesciences Corporation's elevated D/E of 6.57 either reflects an aggressive growth-via-debt strategy or balance sheet stress. Operating cash flow trend is the cleanest tell.
EW's 13.60% revenue growth meaningfully outpaces the market. Whether operating margins expand alongside is the key for multiple justification.
Clinical trial outcomes, FDA decisions, and drug-pricing policy drive most of the short-term volatility.
Edwards Lifesciences Corporation trades in the upper 23% of its 52-week range (72.30β96.29). The uptrend is intact, though how much optimism is already reflected in the price is a separate question worth checking.
The stock moved within a 1.76% high-to-low band on the day, closing 0.41%. That falls within a typical intraday range.
Edwards Lifesciences Corporation has 1 recorded picks from AI discovery and early signals since 2026-08-25. Each entry was written the moment the pick was made and has never been edited or deleted.
No pick has completed its 20-trading-day evaluation yet.
| Date | Source | 5d alpha | 20d alpha |
|---|---|---|---|
| 2026-08-25 | Early Signal | Pending | Pending |
A pick is not a recommendation to buy or sell, and past results do not guarantee future returns. Alpha is the excess return in percentage points after subtracting the benchmark index over the same period.
Your watchlist and portfolio, one tap from your home screen β the Margin Call app
Edwards Lifesciences Corporation (EW) is listed on NYSE, with recent volume of 2,389,738 shares. Volume is a supporting gauge of how much conviction sits behind a price move β the same gain reads differently on heavy versus light turnover.